Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a double-blind, randomized placebo-controlled study.

Ogilvie, G K; Fettman, M J; Mallinckrodt, C H; Walton, J A; Hansen, R A; Davenport, D J; Gross, K L; Richardson, K L; Rogers, Q; Hand, M S

Ogilvie, G K; Fettman, M J; Mallinckrodt, C H; Walton, J A; Hansen, R A; Davenport, D J; Gross, K L; Richardson, K L; Rogers, Q; Hand, M S.

Affiliation

Ogilvie GK; Comparative Oncology Unit, Departments of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.

Cancer ; 88(8): 1916-28, 2000 Apr 15.

Article in En | MEDLINE | ID: mdl-10760770

Subject(s)

Antineoplastic Agents/therapeutic use; Arginine/therapeutic use; Cachexia/prevention & control; Doxorubicin/therapeutic use; Fatty Acids/pharmacology; Fish Oils/pharmacology; Precursor Cell Lymphoblastic Leukemia-Lymphoma/veterinary; Animals; Diet; Dietary Supplements; Disease Models, Animal; Disease-Free Survival; Docosahexaenoic Acids/administration & dosage; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Eicosapentaenoic Acid/administration & dosage; Lactic Acid/blood; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism; Survival Analysis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arginine / Cachexia / Fish Oils / Doxorubicin / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Fatty Acids / Antineoplastic Agents Type of study: Prognostic_studies Aspects: Patient_preference Limits: Animals Language: En Journal: Cancer Year: 2000 Document type: Article

Search on Google

XML

PubMed Links